Company page

Statera Biopharma, Inc.

Statera Biopharma, Inc. is a public company traded under the ticker STAB in the American market. With a market capitalization of approximately $7.14 billion, the company focuses on developing innovative therapies for various medical conditions. Statera aims to enhance patient outcomes through its advanced biopharmaceutical solutions.